Suppr超能文献

[慢性阻塞性疾病的单肺移植]

[Single-lung transplant in chronic obstructive disease].

作者信息

Mal M, Fournier M, Sleiman C, Roué C, Raffy O, Jebrak G, Roux F, Mangiapan G, Duchatelle J P, Kitzis M

机构信息

Service de Pneumologie et Réanimation, Hôpital Beaujon, Clichy.

出版信息

Rev Mal Respir. 1995;12(6):559-66.

PMID:8677350
Abstract

The feasibility and the good immediate acceptability of unilateral lung transplants in the patients with obstructive respiratory problems have recently been demonstrated and since the initial reports, some hundreds of lung transplants have been performed in various parts of the world for this indication. Nevertheless, few results of respiratory function are currently available in the medium term. We report these in a series of 20 patients with severe obstruction who were given single lung transplants. The actual probability of survival for 1 and 2 years was 75 and 70% respectively with 4 peri-operative deaths and 2 later deaths. In the 16 survivors of more than 6 months, in relation to the pre-operative values, a significant improvement was observed 3 months after the graft in the FEV1 which rose from 17 +/- 6 to 53 +/- 13% of the predicted values. The PaO2 rose from 52 +/- 10 to 81 +/- 3 mmHg. The distance covered on the six minute walking test went from 99 +/- 84 m before the graft to 587 +/- 147 m 6 months after the operation. In addition to the improved distance, the lung function was stable in a group of patients as the months went by, although there was a fall in the respiratory function in others with the appearance of the syndrome of bronchiolitis obliterans or in 2 patients with bronchial complications. The four patients with severe deterioration in the graft function were re-transplanted with a good clinical result in three of them, the fourth dying in the immediate post-operative period. We conclude that single lung transplant represents an effective treatment both in the short and medium term in patients with chronic airflow obstruction.

摘要

近期研究已证实,对于患有阻塞性呼吸问题的患者,进行单侧肺移植具有可行性且即刻接受度良好。自最初的报道以来,全球各地已针对这一适应症进行了数百例肺移植手术。然而,目前关于中期呼吸功能的结果却寥寥无几。我们报告了一组20例患有严重阻塞性疾病并接受单肺移植的患者的相关情况。1年和2年的实际生存率分别为75%和70%,围手术期死亡4例,后期死亡2例。在16例存活超过6个月的患者中,与术前值相比,移植后3个月时FEV1有显著改善,从预测值的17±6%升至53±13%。动脉血氧分压(PaO2)从52±10 mmHg升至81±3 mmHg。六分钟步行试验的距离从移植前的99±84米增加到术后6个月的587±147米。除了步行距离增加外,随着时间推移,一组患者的肺功能保持稳定,尽管其他一些患者出现闭塞性细支气管炎综合征或支气管并发症导致呼吸功能下降。4例移植功能严重恶化的患者接受了再次移植,其中3例临床效果良好,第4例在术后即刻死亡。我们得出结论,对于慢性气流阻塞患者,单肺移植在短期和中期均是一种有效的治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验